Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 30:2019:8630871.
doi: 10.1155/2019/8630871. eCollection 2019.

Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs

Devis Benfaremo  1 , Michele Maria Luchetti  1 , Armando Gabrielli  1
Affiliations
Review

Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs

Devis Benfaremo et al. J Immunol Res. .

Abstract

Inflammatory bowel disease-associated spondyloarthritis is a systemic disease characterized by the chronic inflammation of both the gastrointestinal tract and the musculoskeletal system. Since inflammatory bowel disease-associated spondyloarthritis has been associated with a significant diagnostic delay, which may lead to poor quality of life and progression of joint damage, efforts to discover new reliable and noninvasive diagnostic biomarkers have been made. We reviewed the state of the art of biomarker research in inflammatory bowel disease-associated spondyloarthritis, showing that to date it has been largely unsatisfactory. Only a few of the biomarkers that have been investigated are likely to enter the clinical practice upon further validation in independent cohorts. The research of new and innovative biomarkers for inflammatory bowel disease-associated spondyloarthritis is warranted.

PubMed Disclaimer

References

    1. Salvarani C., Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World Journal of Gastroenterology. 2009;15(20):2449–2455. doi: 10.3748/wjg.15.2449. - DOI - PMC - PubMed
    1. Rudwaleit M., van der Heijde D., Landewe R., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Annals of the Rheumatic Diseases. 2009;68(6):777–783. doi: 10.1136/ard.2009.108233. - DOI - PubMed
    1. D’Incà R., Podswiadek M., Ferronato A., Punzi L., Salvagnini M., Sturniolo G. C. Articular manifestations in inflammatory bowel disease patients: a prospective study. Digestive and Liver Disease. 2009;41(8):565–569. doi: 10.1016/j.dld.2009.01.013. - DOI - PubMed
    1. Gracey E., Dumas E., Yerushalmi M., Qaiyum Z., Inman R. D., Elewaut D. The ties that bind: skin, gut and spondyloarthritis. Current Opinion in Rheumatology. 2019;31(1):62–69. doi: 10.1097/BOR.0000000000000569. - DOI - PubMed
    1. Karreman M. C., Luime J. J., Hazes J. M. W., Weel A. E. A. M. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. Journal of Crohn's and Colitis. 2017;11(5):631–642. doi: 10.1093/ecco-jcc/jjw199. - DOI - PubMed

LinkOut - more resources